United States Healthcare Equipment & Supplies

HeartSciences Inc (HSCS)

HeartSciences Inc. has recorded no insider trading activity within the past ninety days. The most recent transactions occurred on July 29, 2025, involving planned and proposed sales by Mark T. Hilz, who serves as an officer and director. Given these events transpired over three months ago, no current market performance context is provided.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: HSCS Exchange: NAS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for HeartSciences Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

HILZ MARK T COO, Secretary and Director Executive Director

Transaction date 29 Jul 2025

Planned sale

Price

192.24

Quantity 93,935 +38.4%

Value US$4,516,920

Comments Filing

HILZ MARK T Officer; Director Executive Director

Transaction date 29 Jul 2025

Proposed sale

Price

131.03

Quantity 91,864

Value US$4,137,326

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-07-30	2025-07-29	PlS Planned sale	HILZ MARK T COO, Secretary and Director Executive Director	93,935 +38.4% 192.24 US$4,516,920	93,935 +38.4%	192.24	US$4,516,920
2025-07-29	2025-07-29	PrS Proposed sale	HILZ MARK T Officer; Director Executive Director	91,864 131.03 US$4,137,326	91,864	131.03	US$4,137,326